Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 118

Similar articles for PubMed (Select 9607014)

3.
4.

Synthetic peptides representing T-cell epitopes act as carriers in pneumococcal polysaccharide conjugate vaccines.

de Velasco EA, Merkus D, Anderton S, Verheul AF, Lizzio EF, Van der Zee R, Van Eden W, Hoffman T, Verhoef J, Snippe H.

Infect Immun. 1995 Mar;63(3):961-8.

5.
6.

Cross-reactivity of antibodies to type 6B and 6A polysaccharides of Streptococcus pneumoniae, evoked by pneumococcal conjugate vaccines, in infants.

Väkeväinen M, Eklund C, Eskola J, Käyhty H.

J Infect Dis. 2001 Sep 15;184(6):789-93. Epub 2001 Aug 14.

7.

Serum samples from infants vaccinated with a pneumococcal conjugate vaccine, PncT, protect mice against invasive infection caused by Streptococcus pneumoniae serotypes 6A and 6B.

Saeland E, Jakobsen H, Ingolfsdottir G, Sigurdardottir ST, Jonsdottir I.

J Infect Dis. 2001 Jan 15;183(2):253-260. Epub 2000 Dec 8.

8.

Differences in the avidity of antibodies evoked by four different pneumococcal conjugate vaccines in early childhood.

Anttila M, Eskola J, Ahman H, Käyhty H.

Vaccine. 1999 Apr 9;17(15-16):1970-7.

PMID:
10217596
9.

Studies on vaccine control and immunogenicity of polysaccharides of Streptococcus pneumoniae.

Lee CJ, Lin KT.

Rev Infect Dis. 1981 Mar-Apr;3 Suppl:S51-60. Review.

PMID:
6169130
10.
11.
12.

Comparative immunogenicity of group 6 pneumococcal type 6A(6) and type 6B(26) capsular polysaccharides.

Robbins JB, Lee CJ, Rastogi SC, Schiffman G, Henrichsen J.

Infect Immun. 1979 Dec;26(3):1116-22.

13.
14.

Response to a heptavalent conjugate Streptococcus pneumoniae vaccine in children with recurrent infections who are unresponsive to the polysaccharide vaccine.

Sorensen RU, Leiva LE, Giangrosso PA, Butler B, Javier FC 3rd, Sacerdote DM, Bradford N, Moore C.

Pediatr Infect Dis J. 1998 Aug;17(8):685-91.

PMID:
9726341
15.
16.

Protective immunity of pneumococcal glycoconjugates.

Lee CJ, Lee LH, Frasch CE.

Crit Rev Microbiol. 2003;29(4):333-49. Review.

PMID:
14636043
17.

IgG subclass distribution of antibodies after vaccination of adults with pneumococcal conjugate vaccines.

Soininen A, Seppälä I, Nieminen T, Eskola J, Käyhty H.

Vaccine. 1999 Apr 9;17(15-16):1889-97.

PMID:
10217586
18.

A comparative study of the immunogenicity of pneumococcal type 4 polysaccharide and oligosaccharide tetanus toxoid conjugates in adult mice.

Peeters CC, Tenbergen-Meekes AM, Evenberg DE, Poolman JT, Zegers BJ, Rijkers GT.

J Immunol. 1991 Jun 15;146(12):4308-14.

PMID:
2040803
19.

Mucosal vaccination against encapsulated respiratory bacteria--new potentials for conjugate vaccines?

Jakobsen H, Jonsdottir I.

Scand J Immunol. 2003 Aug;58(2):119-28. Review.

PMID:
12869132
20.

Self heat-shock protein (hsp60) peptide serves in a conjugate vaccine against a lethal pneumococcal infection.

Könen-Waisman S, Cohen A, Fridkin M, Cohen IR.

J Infect Dis. 1999 Feb;179(2):403-13.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk